Literature DB >> 23782794

Association between behavioral and psychological symptoms and psychotropic drug use among old people with cognitive impairment living in geriatric care settings.

Maria Gustafsson1, Per-Olof Sandman, Stig Karlsson, Yngve Gustafson, Hugo Lövheim.   

Abstract

BACKGROUND: Behavioral and psychological symptoms are common among cognitively impaired individuals and psychotropic drugs are widely used for their treatment. The aim of this study was to describe the prevalence and associated factors of psychotropic and anti-dementia drug use among old people with cognitive impairment living in geriatric care settings.
METHODS: The study comprised 2,019 cognitively impaired people living in geriatric care units in the county of Västerbotten, Sweden. Data concerning psychotropic and anti-dementia drug use, function in activities of daily living, cognitive function, and prevalence of behavioral and psychological symptoms were collected, using the Multi-Dimensional Dementia Assessment Scale.
RESULTS: Of the study population, 1,442 individuals (71%) were prescribed at least one psychotropic drug (antidepressants (49%), anxiolytics, hypnotics, and sedatives (36%), antipsychotics (25%)). Furthermore, 363 individuals (18%) received anti-dementia drugs. Associations between various behavioral and psychological symptoms were found for all psychotropic drug classes and anti-dementia drugs. Verbally disruptive/attention-seeking behavior was associated with all psychotropic drugs. Use of antipsychotics was associated with several behavioral and psychological symptoms, including aggressive behavior.
CONCLUSION: The associations between behavioral and psychological symptoms and psychotropic drug use found in this study indicate that these drugs are prescribed to treat behavioral and psychological symptoms among cognitively impaired individuals despite limited evidence of their efficacy. Given the significant risk of adverse effects among old people with cognitive impairment, it is important to ensure that any medication used is both appropriate and safe.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23782794     DOI: 10.1017/S1041610213000859

Source DB:  PubMed          Journal:  Int Psychogeriatr        ISSN: 1041-6102            Impact factor:   3.878


  16 in total

Review 1.  Antipsychotic Use in Dementia.

Authors:  Julia Kirkham; Chelsea Sherman; Clive Velkers; Colleen Maxwell; Sudeep Gill; Paula Rochon; Dallas Seitz
Journal:  Can J Psychiatry       Date:  2016-10-08       Impact factor: 4.356

2.  Trends in Antipsychotic and Mood Stabilizer Prescribing in Long-Term Care in the U.S.: 2011-2014.

Authors:  Lauren B Gerlach; Helen C Kales; Hyungjin Myra Kim; Julie P W Bynum; Claire Chiang; Julie Strominger; Donovan T Maust
Journal:  J Am Med Dir Assoc       Date:  2020-07-18       Impact factor: 4.669

3.  Behavioral and psychological symptoms and psychotropic drugs among people with cognitive impairment in nursing homes in 2007 and 2013.

Authors:  Maria Gustafsson; Ulf Isaksson; Stig Karlsson; Per-Olof Sandman; Hugo Lövheim
Journal:  Eur J Clin Pharmacol       Date:  2016-04-13       Impact factor: 2.953

4.  Trends in treatment with antipsychotic medication in relation to national directives, in people with dementia - a review of the Swedish context.

Authors:  Staffan Karlsson; Ingalill Rahm Hallberg; Patrik Midlöv; Cecilia Fagerström
Journal:  BMC Psychiatry       Date:  2017-07-14       Impact factor: 3.630

5.  Dysphoric symptoms in relation to other behavioral and psychological symptoms of dementia, among elderly in nursing homes.

Authors:  Agnes Lindbo; Maria Gustafsson; Ulf Isaksson; Per-Olof Sandman; Hugo Lövheim
Journal:  BMC Geriatr       Date:  2017-09-07       Impact factor: 3.921

6.  Psychotropic drug use and mortality in old people with dementia: investigating sex differences.

Authors:  Jon Brännström; Gustaf Boström; Erik Rosendahl; Peter Nordström; Håkan Littbrand; Hugo Lövheim; Yngve Gustafson
Journal:  BMC Pharmacol Toxicol       Date:  2017-05-25       Impact factor: 2.483

7.  Resourse Use and Disease Couse in dementia - Nursing Home (REDIC-NH), a longitudinal cohort study; design and patient characteristics at admission to Norwegian nursing homes.

Authors:  Irene Røen; Geir Selbæk; Øyvind Kirkevold; Knut Engedal; Ingelin Testad; Sverre Bergh
Journal:  BMC Health Serv Res       Date:  2017-05-22       Impact factor: 2.655

8.  Drug-related problems and medication reviews among old people with dementia.

Authors:  Bettina Pfister; Jeanette Jonsson; Maria Gustafsson
Journal:  BMC Pharmacol Toxicol       Date:  2017-06-27       Impact factor: 2.483

9.  Use of anti-dementia drugs in home care and residential care and associations with neuropsychiatric symptoms: a cross-sectional study.

Authors:  Marja Kuronen; Hannu Koponen; Irma Nykänen; Pertti Karppi; Sirpa Hartikainen
Journal:  BMC Geriatr       Date:  2015-08-13       Impact factor: 3.921

10.  Psychotropic drug use among people with dementia--a six-month follow-up study.

Authors:  Maria Gustafsson; Stig Karlsson; Yngve Gustafson; Hugo Lövheim
Journal:  BMC Pharmacol Toxicol       Date:  2013-11-07       Impact factor: 2.483

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.